The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation

EGFR-mediated tumors have been targeted to overcome several different malignant cancers. EGFR overexpression and mutations are directly related to the malignancy, which makes the therapy more complicated. One reason for the malignancy is the induction of AP1 followed by inflammation via IL-6 secreti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Woo Jung, Kim, Dohyang, Zhu, Anlin, Cho, Namki, Yoo, Hee Min, Noh, Ji Heon, Kim, Kyoung Mi, Lee, Hyun-Su, Hong, Jaewoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691834/
https://www.ncbi.nlm.nih.gov/pubmed/36438839
http://dx.doi.org/10.3389/fphar.2022.1050758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691834/
https://www.ncbi.nlm.nih.gov/pubmed/36438839
http://dx.doi.org/10.3389/fphar.2022.1050758

Ejemplares similares